Výsledky vyhľadávania - "and Proteins::Proteins::Mutant Proteins::Mutant Chimeric Proteins::Oncogene Proteins"

Clinical Value of Liquid Biopsy in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma During Targeted Therapy

Autori: Alberto González-Medina Maria Vila-Casadesús Marina Gomez-Rey a ďalší

Prispievatelia: Alberto González-Medina Maria Vila-Casadesús Marina Gomez-Rey a ďalší

Zdroj: Clin Cancer Res
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname

Predmety: ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias glandulares y epiteliales::carcinoma::adenocarcinoma::colangiocarcinoma, Male, Adult, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::farmacoterapia::terapia molecular selectiva, Oncogene Proteins, Fusion, Conductes biliars - Càncer - Tractament, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas mutantes::proteínas mutantes quiméricas::proteínas oncogénicas de fusión, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Drug Therapy::Molecular Targeted Therapy, Circulating Tumor DNA, Cholangiocarcinoma, Adenocarcinoma - Càncer - Tractament, Conductes biliars - Biòpsia, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::técnicas y procedimientos diagnósticos::técnicas de laboratorio clínico::técnicas citológicas::citodiagnóstico::biopsia::biopsia líquida, Biomarkers, Tumor, CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Mutant Proteins::Mutant Chimeric Proteins::Oncogene Proteins, Fusion, Humans, Medicina personalitzada, Molecular Targeted Therapy, Receptor, Fibroblast Growth Factor, Type 2, Protein Kinase Inhibitors, Aged, Retrospective Studies, Translational Cancer Mechanisms and Therapy, Other subheadings::Other subheadings::Other subheadings::/drug therapy, Liquid Biopsy, High-Throughput Nucleotide Sequencing, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques::Cytological Techniques::Cytodiagnosis::Biopsy::Liquid Biopsy, Middle Aged, Prognosis, Bile Duct Neoplasms, Female, DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Glandular and Epithelial::Carcinoma::Adenocarcinoma::Cholangiocarcinoma

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39078735
https://hdl.handle.net/11351/12188

The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring NRG1 gene fusions

Autori: Dong-Wan Kim Alison M Schram Antoine Hollebecque a ďalší

Prispievatelia: Dong-Wan Kim Alison M Schram Antoine Hollebecque a ďalší

Zdroj: Future Oncol
Scientia

Predmety: Oncogens, Adult, Male, CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal::Antibodies, Monoclonal, Humanized, recruiting, Clinical Trial Protocol, Lung Neoplasms, Oncogene Proteins, Fusion, Receptor, ErbB-3, Other subheadings::Other subheadings::/therapeutic use, Receptor, ErbB-2, Neuregulin-1, Otros calificadores::Otros calificadores::/uso terapéutico, Medicaments antineoplàstics - Ús terapèutic, [SDV.CAN]Life Sciences [q-bio]/Cancer, COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::inmunoglobulinas::anticuerpos::anticuerpos monoclonales::anticuerpos monoclonales humanizados, NSCLC, COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas mutantes::proteínas mutantes quiméricas::proteínas oncogénicas de fusión, Antibodies, Monoclonal, Humanized, DISEASES::Neoplasms::Neoplasms::Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Pancreatic Neoplasms::Neoplasms::Neoplasms by Site::Carcinoma, Pancreatic Ductal, Antineoplastic Agents, Immunological, Clinical Trials, Phase II as Topic, HER3, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos::inmunoterapia antineoplásica, HER2, Carcinoma, Non-Small-Cell Lung, Neoplasms, NRG1 fusion, Pàncrees - Càncer - Tractament, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents::Antineoplastic Agents, Immunological, CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Mutant Proteins::Mutant Chimeric Proteins::Oncogene Proteins, Fusion, Humans, Multicenter Studies as Topic, Zenocutuzumab, Anticossos monoclonals - Ús terapèutic, Clinical Trials, Phase I as Topic, ENFERMEDADES::neoplasias::neoplasias::neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias pancreáticas::neoplasias::neoplasias por localización::carcinoma ductal pancreático, PDAC, Zeno, NRG1+, Middle Aged, DISEASES::Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias torácicas::neoplasias del tracto respiratorio::neoplasias pulmonares::neoplasias de los bronquios::carcinoma broncogénico::carcinoma de pulmón de células no pequeñas, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, Female, eNRGy trial, Pulmons - Càncer - Tractament, Carcinoma, Pancreatic Ductal

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38348690
https://hdl.handle.net/11351/12567

Treatment of Pediatric, Adolescent, and Young Adult Patients With Fusion-Positive Alveolar Rhabdomyosarcoma Infiltrating Regional Lymph Nodes in the European CWS-2002P and RMS 2005 Studies and the Soft Tissue Sarcoma Registry

Autori: Heinz, Amadeus Tilman Ciuffolotti, Melissa Merks, Johannes a ďalší

Prispievatelia: Heinz, Amadeus Tilman Ciuffolotti, Melissa Merks, Johannes a ďalší

Zdroj: Scientia

Predmety: Registres mèdics, Registres hospitalaris, Tumors de parts toves - Tractament, Metàstasi limfàtica, Adolescents, DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Connective and Soft Tissue::Neoplasms, Muscle Tissue::Myosarcoma::Rhabdomyosarcoma::Rhabdomyosarcoma, Alveolar, Other subheadings::Other subheadings::/therapy, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Combined Modality Therapy, AND EQUIPMENT::Investigative Techniques::Epidemiologic Methods::Data Collection::Registries, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Metastasis::Lymphatic Metastasis, CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Mutant Proteins::Mutant Chimeric Proteins::Oncogene Proteins, Fusion, NAMED GROUPS::Persons::Age Groups::Adolescent, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias de tejido conjuntivo y de tejidos blandos::neoplasias de tejido muscular::miosarcoma::rabdomiosarcoma::rabdomiosarcoma alveolar, Otros calificadores::Otros calificadores::/terapia, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::tratamiento combinado, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos epidemiológicos::recopilación de datos::registros, ENFERMEDADES::neoplasias::procesos neoplásicos::metástasis neoplásica::metástasis linfática, COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas mutantes::proteínas mutantes quiméricas::proteínas oncogénicas de fusión, DENOMINACIONES DE GRUPOS::personas::Grupos de Edad::adolescente

Popis súboru: application/pdf

Relation: Pediatric Blood & Cancer;72(3); https://doi.org/10.1002/pbc.31476; https://hdl.handle.net/11351/12687; 001373821100001

Dostupnosť: https://hdl.handle.net/11351/12687
https://doi.org/10.1002/pbc.31476

RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion

Autori: Aldea, Mihaela Marinello, Arianna Duruisseaux, Michaël a ďalší

Prispievatelia: Aldea, Mihaela Marinello, Arianna Duruisseaux, Michaël a ďalší

Zdroj: Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
Aldea, M, Marinello, A, Duruisseaux, M, Zrafi, W, Conci, N, Massa, G, Metro, G, Monnet, I, Gomez Iranzo, P, Tabbo, F, Bria, E, Guisier, F, Vasseur, D, Lindsay, C R, Ponce-Aix, S, Cousin, S, Citarella, F, Fallet, V, Minatta, J N, Eisert, A, de Saint Basile, H, Audigier-Valette, C, Mezquita, L, Calles, A, Mountzios, G, Tagliamento, M, Remon Masip, J, Raimbourg, J, Terrisse, S, Russo, A, Cortinovis, D, Rochigneux, P, Pinato, D J, Cortellini, A, Leonce, C, Gazzah, A, Ghigna, M-R, Ferrara, R, Dall'Olio, F G, Passiglia, F, Ludovini, V, Barlesi, F, Felip, E, Planchard, D & Besse, B 2023, 'Ret-map : An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion', Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, vol. 18, no. 5, pp. 576-586. https://doi.org/10.1016/j.jtho.2022.12.018

Predmety: MESH: Carcinoma, Male, Lung Neoplasms, RET inhibitors, Pulmons - Càncer - Aspectes genètics, [SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, RET fusion, chemotherapy, immunotherapy, non-small cell lung cancer, Otros calificadores::Otros calificadores::Otros calificadores::/genética, Carcinoma, Non-Small-Cell Lung, Non-Small-Cell Lung, In Situ Hybridization, In Situ Hybridization, Fluorescence, MESH: Treatment Outcome, MESH: Middle Aged, Adenocarcinoma/pathology, Chemotherapy, Immunotherapy, Non–small cell lung cancer, Middle Aged, DISEASES::Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung, 3. Good health, Treatment Outcome, [SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, Female, [SDV.IMM.IMM] Life Sciences [q-bio]/Immunology/Immunotherapy, Other subheadings::Other subheadings::Other subheadings::/genetics, [SDV.CAN]Life Sciences [q-bio]/Cancer, Adenocarcinoma, COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas mutantes::proteínas mutantes quiméricas::proteínas oncogénicas de fusión, Fluorescence, MESH: In Situ Hybridization, [SDV.CAN] Life Sciences [q-bio]/Cancer, CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Mutant Proteins::Mutant Chimeric Proteins::Oncogene Proteins, Fusion, Humans, Lung Neoplasms/drug therapy, MESH: Humans, MESH: Adenocarcinoma, Carcinoma, [SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias torácicas::neoplasias del tracto respiratorio::neoplasias pulmonares::neoplasias de los bronquios::carcinoma broncogénico::carcinoma de pulmón de células no pequeñas, MESH: Male, MESH: Lung Neoplasms, Anomalies cromosòmiques, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, Carcinoma, Non-Small-Cell Lung/pathology, [SDV.MHEP.PSR] Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Non-Small-Cell Lung/pathology, MESH: Female

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/36646211
https://hdl.handle.net/11351/9472
https://research.manchester.ac.uk/en/publications/3cd411fe-46f3-48c6-9377-ae6726499919
https://doi.org/10.1016/j.jtho.2022.12.018
https://hdl.handle.net/20.500.11768/176598
https://doi.org/10.1016/j.jtho.2022.12.018
https://www.jto.org/action/showPdf?pii=S1556-0864(22)01994-3
https://hdl.handle.net/2434/1124063
https://doi.org/10.1016/j.jtho.2022.12.018
https://hdl.handle.net/10281/531003
https://doi.org/10.1016/j.jtho.2022.12.018
https://hal.science/hal-04176638v1
https://hal.science/hal-04176638v1/document
https://doi.org/10.1016/j.jtho.2022.12.018
https://hdl.handle.net/10807/302000
https://doi.org/10.1016/j.jtho.2022.12.018
https://hdl.handle.net/11567/1156377
https://doi.org/10.1016/j.jtho.2022.12.018
http://www.scopus.com/inward/record.url?scp=85149658996&partnerID=8YFLogxK
https://www.mendeley.com/catalogue/573f6264-5b5e-3117-a16e-0393cd88fd67/
https://research.manchester.ac.uk/en/publications/3cd411fe-46f3-48c6-9377-ae6726499919
https://doi.org/10.1016/j.jtho.2022.12.018
https://hdl.handle.net/11391/1590736
https://doi.org/10.1016/j.jtho.2022.12.018
https://www.jto.org/article/S1556-0864(22)01994-3/fulltext
https://hdl.handle.net/2318/1887421
https://doi.org/10.1016/j.jtho.2022.12.018